These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33063839)

  • 1. Reply to The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers.
    Saslow D; Andrews KS; Manassaram-Baptiste D; Smith RA; Fontham ETH
    CA Cancer J Clin; 2020 Nov; 70(6):519-520. PubMed ID: 33063839
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers.
    Kacew AJ; Grimes AC; Roth M; Teoh D; Landier W; Strohbehn GW; Paskett ED
    CA Cancer J Clin; 2020 Nov; 70(6):518-519. PubMed ID: 33063840
    [No Abstract]   [Full Text] [Related]  

  • 3. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic HPV vaccination for the prevention of cervical cancer.
    Hernandez BY
    Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858
    [No Abstract]   [Full Text] [Related]  

  • 5. Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US.
    Tabibi T; Barnes JM; Shah A; Osazuwa-Peters N; Johnson KJ; Brown DS
    JAMA Pediatr; 2022 Mar; 176(3):313-316. PubMed ID: 34842903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers.
    Lehtinen M; Gray P; Louvanto K; Vänskä S
    Expert Rev Vaccines; 2022 Jun; 21(6):735-738. PubMed ID: 35404177
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in human papillomavirus vaccination among women aged 27 to 45 years, from 2017 to 2019.
    Kulkarni A; Chen L; Melamed A; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2022 Apr; 226(4):568-570.e1. PubMed ID: 34953774
    [No Abstract]   [Full Text] [Related]  

  • 8. Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.
    Temkin SM; Seibel NL
    Cancer; 2015 Oct; 121(19):3395-402. PubMed ID: 26110510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
    Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
    Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
    [No Abstract]   [Full Text] [Related]  

  • 11. Rural-Urban Differences in Human Papillomavirus Vaccination Among Young Adults in 8 U.S. States.
    Lee M; Gerend MA; Adjei Boakye E
    Am J Prev Med; 2021 Feb; 60(2):298-299. PubMed ID: 33067069
    [No Abstract]   [Full Text] [Related]  

  • 12. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    Cody P; Tobe K; Abe M; Elbasha EH
    BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bandicoots, bonobos, and boys: papillomavirus and vaccination strategies.
    Grose C
    Pediatrics; 2009 Apr; 123(4):1244-5. PubMed ID: 19336384
    [No Abstract]   [Full Text] [Related]  

  • 14. The Impact of Human Papillomavirus Catch-Up Vaccination in Australia: Implications for Introduction of Multiple Age Cohort Vaccination and Postvaccination Data Interpretation.
    Drolet M; Laprise JF; Brotherton JML; Donovan B; Fairley CK; Ali H; Bénard É; Martin D; Brisson M
    J Infect Dis; 2017 Dec; 216(10):1205-1209. PubMed ID: 28968800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
    Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
    Vetter KM; Geller SE
    J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of catch-up in vaccination against human papillomavirus in medium- and low-income countries.
    Baussano I; Lazzarato F; Ronco G; Dillner J; Franceschi S
    Int J Cancer; 2013 Oct; 133(8):1876-81. PubMed ID: 23564420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cervical HPV infection; epidemiology and vaccination].
    Yoshikawa H
    Kansenshogaku Zasshi; 2008 Nov; 82(6):609-12. PubMed ID: 19086414
    [No Abstract]   [Full Text] [Related]  

  • 20. [Human papillomavirus vaccination : pharmacovigilance data].
    Dib F; Launay O
    Rev Prat; 2020 Jan; 70(1):96-98. PubMed ID: 32877039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.